Therefore, the utilization of naturally occurring NRF2 activators which share antioxidant and anti-inflammatory efficacies in CKD may be a promising strategy to ameliorate or retard kidney dysfunction. The gene discussed is NFE2L2; the disease is chronic kidney disease.